Reuters logo
BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial
2017年10月17日 / 下午12点53分 / 1 个月前

BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial

Oct 17 (Reuters) - Xenon Pharmaceuticals Inc

* Xenon Pharmaceuticals announces initiation of XEN1101 phase 1 clinical trial

* XEN1101 phase 2 proof-of-concept clinical trial anticipated to begin in Q3 2018​

* Expect to file an IND equivalent application in Q4 of this year for XEN901​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below